Michael Sprintz, D.O., DFASAM

Dr. Sprintz received his Medical Degree from Chicago College of Osteopathic Medicine and went on to a residency in Anesthesiology at Johns Hopkins Hospital and University of South Florida, then completed a Pain Medicine Fellowship at MD Anderson Cancer Center. Dr. Sprintz is board-certified in Pain Medicine, Addiction Medicine, and Anesthesiology, and is personally in recovery from drug addiction for over 18 years. Dr. Sprintz is the founder of Sprintz Center for Pain and Recovery- an integrated outpatient private practice that specializes in the comprehensive management of chronic pain and substance use disorders.

Dr. Sprintz is also the founder and CEO of Cellarian, Inc., which develops software that helps providers rapidly predict, identify, document and monitor patients at-risk for opioid and other substance use disorders. The CellarianRx platform is a user-friendly, intuitive PMP visualization tool with predictive analytics and clinical decision support that improves patient care, compliance, and practice efficiency. CellarianRx decreases risk and cost for providers and health systems, payers and patients, while empowering the transition to value-based care delivery.

Dr. Sprintz serves as a consultant to the FDA’s Analgesic and Anesthetic Drug Products Advisory Committee and is a member of the Joint Commission Standards Review Panel for Pain Assessment and Management, as well as the Joint Commission’s Technical Advisory Panel for Pain Assessment and Management in Behavioral Healthcare. Dr. Sprintz is the Past-President of the Texas Society of Addiction Medicine, and a member of the American Society of Addiction Medicine’s Drug Testing Expert Panel, Payer Relations Committee, and the Pain and Addiction Educational Program Planning Committee.